UK drug giant teams up with French rival for Covid-19 vaccine

GlaxoSmithKline hopes to have coronavirus treatment available next year

GSK
(Image credit: (Ben Stansall/AFP via Getty Images))

A leading British drug company is joining forces with a French rival to develop a coronavirus vaccine and manufacture hundreds of millions of doses.

GlaxoSmithKline is to team up with Sanofi on a treatment that they hope to test on humans during the second half of 2020 and make available a year later if regulators grant approval.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up